Order Article Reprints

Mäurer M, Schott D, Pizon M, Drozdz S, Wendt T, Wittig A, Pachmann K. Increased Circulating Epithelial Tumor Cells (CETC/CTC) over the Course of Adjuvant Radiotherapy Is a Predictor of Less Favorable Outcome in Patients with Early-Stage Breast Cancer. Current Oncology. 2023; 30(1):261-273. https://doi.org/10.3390/curroncol30010021

Mäurer, Matthias, Dorothea Schott, Monika Pizon, Sonia Drozdz, Thomas Wendt, Andrea Wittig, and Katharina Pachmann. 2023. "Increased Circulating Epithelial Tumor Cells (CETC/CTC) over the Course of Adjuvant Radiotherapy Is a Predictor of Less Favorable Outcome in Patients with Early-Stage Breast Cancer" Current Oncology 30, no. 1: 261-273. https://doi.org/10.3390/curroncol30010021

Mäurer, M., Schott, D., Pizon, M., Drozdz, S., Wendt, T., Wittig, A., & Pachmann, K. (2023). Increased Circulating Epithelial Tumor Cells (CETC/CTC) over the Course of Adjuvant Radiotherapy Is a Predictor of Less Favorable Outcome in Patients with Early-Stage Breast Cancer. Current Oncology, 30(1), 261-273. https://doi.org/10.3390/curroncol30010021